Market cap
₹3 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
56.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-1 Cr
-
ROE
-58.9 %
-
ROCE
-9.7 %
-
Industry P/E
51.18
-
EV/EBITDA
-12.1
-
Debt to Equity
0
-
Book Value
₹0
-
EPS
₹-0.5
-
Face value
10
-
Shares outstanding
19,111,400
10 Years Aggregate
CFO
₹-5.95 Cr
EBITDA
₹-16.60 Cr
Net Profit
₹-19.19 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Advik Pharmaa
| -2.2 | 4.6 | 9.7 | -34.4 | -7.8 | 11.3 | -11.0 |
|
BSE Healthcare*
| 8.6 | -0.1 | 10.2 | 7.2 | 23.7 | 13.2 | 12.1 |
|
Company
|
2025
|
2024
|
2019
|
|---|---|---|---|
|
Advik Pharmaa
| -56.1 | 50.9 | -83.2 |
|
BSE Small Cap
| -6.6 | 29.0 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Advik Pharmaa
|
1.8 | 3.5 | 0.0 | -1.0 | -- | -286.1 | -- | 56.9 |
| 1,043.0 | 12,906.7 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.9 | 3.9 | |
| 507.5 | 8,749.6 | 947.3 | 247.8 | 28.5 | 18.9 | 35.3 | 6.4 | |
| 1,370.0 | 14,448.0 | 1,054.9 | 256.3 | 27.8 | 13.7 | 55.4 | 7.2 | |
| 1,735.4 | 32,327.5 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35 | 6.5 | |
| 385.7 | 4,197.3 | 165.8 | 46.7 | 37.8 | 16.9 | 89.9 | 14.6 | |
| 16,610.0 | 21,873.6 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.1 | 11.7 | |
| 947.5 | 4,872.1 | 811.3 | 21.0 | 0.7 | 2.1 | 237.1 | 3.8 | |
| 1,255.0 | 5,904.3 | 649.5 | 121.6 | 23.7 | 13.2 | 51.2 | 6.3 | |
| 262.9 | 7,112.5 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Advik Pharmaa
Advik Laboratories Limited manufactures, markets, trades, and exports pharmaceutical products. It offers generic products, such as antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis,... corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products; and ethical products. The company markets and sells its products in India, the Middle East, South America, and Africa. Advik Laboratories Limited was founded in 1994 and is based in New Delhi, India. Read more
-
Incorporated
1994
-
Chairman
--
-
Managing Director
Peeyush Kumar Aggarwal
-
Headquarters
Mewat Dist, Haryana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Advik Pharmaa
What is the current share price of Advik Laboratories Ltd Today?
The share price of Advik Laboratories Ltd is ₹1.81 (BSE) as of 15-Jun-2026 IST. Advik Laboratories Ltd has given a return of -7.81% in the last 3 years.
What is the current PB & PE ratio of Advik Laboratories Ltd?
Since, TTM earnings of Advik Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Advik Laboratories Ltd is 56.92 times as on 15-Jun-2026, a 1406 premium to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
5.62
|
|
2024
|
0.00
|
3.12
|
|
2023
|
0.00
|
1.44
|
|
2022
|
0.00
|
0.69
|
|
2021
|
0.00
|
0.36
|
What is the 52 Week High and Low of Advik Laboratories Ltd?
The 52-week high and low of Advik Laboratories Ltd are Rs 3.01 and Rs 1.57 as of 16-Jun-2026.
What is the market cap of Advik Laboratories Ltd?
Advik Laboratories Ltd has a market capitalisation of ₹ 3 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Advik Laboratories Ltd?
Before investing in Advik Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.